Geovax Labs, INC. (GOVX) — S-1 Filings
All S-1 filings from Geovax Labs, INC.. Browse 5 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (5)
-
GeoVax Launches $0.41 Unit Offering Amidst Going Concern Warning
— Dec 12, 2025 Risk: high
GeoVax Labs, Inc. (GOVX) is conducting a best efforts public offering of 18,292,683 Common Units at an assumed price of $0.41 per Unit, each consisting of one s -
GeoVax Faces 'Going Concern' Amidst Deep Losses, Seeks Funding for Pipeline
— Oct 17, 2025 Risk: high
GeoVax Labs, Inc. (GOVX), a clinical-stage biotechnology company, is facing significant financial challenges, evidenced by a net loss of approximately $10.7 mil -
GeoVax Seeks $25M Via ATM, Registers Warrants for Future Funding
— Jun 16, 2025 Risk: high
GeoVax Labs, Inc. (GOVX) filed an S-1 to register 10,000,000 shares of common stock and 15,000,000 shares of common stock underlying warrants, along with 10,000 -
GeoVax Labs Files S-1 Amidst Corporate Changes
— Sep 6, 2024 Risk: medium
GeoVax Labs, Inc. filed an S-1 form on September 6, 2024, detailing its financial status and future plans. The company, incorporated in Delaware, is in the phar -
GeoVax Labs Files S-1 with SEC
— Jun 7, 2024 Risk: medium
GeoVax Labs, Inc. filed an S-1 form on June 7, 2024, detailing its financial status and business operations. The company, previously known as Dauphin Technology
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX